Central Serous Chorioretinopathy: Pathogenesis and Management.

Area of Science:

• Ophthalmology
• Retinal Diseases
• Medical Interventions

Background:

• Central serous chorioretinopathy (CSC) is a prevalent retinal disease with a high recurrence rate.
• The exact etiology and pathogenesis of CSC remain largely ambiguous.
• While often self-limiting, CSC can lead to irreversible vision loss from photoreceptor damage or retinal pigment epithelium atrophy.

Purpose of the Study:

• To review the current understanding of Central serous chorioretinopathy (CSC).
• To evaluate the efficacy of various interventions for acute CSC.
• To identify the most promising treatment options for CSC.

Main Methods:

• Review of existing literature on Central serous chorioretinopathy (CSC) interventions.
• Analysis of studies evaluating laser treatment, photodynamic therapy (PDT), and anti-VEGF agents.
• Assessment of the clinical benefits of treating acute CSC versus spontaneous resolution.

Main Results:

• The benefits of treating acute Central serous chorioretinopathy (CSC) are not definitively established.
• Several interventions exist, including laser treatments, PDT, and anti-VEGF injections.
• Photodynamic therapy (PDT) and micropulse laser treatment emerge as the most promising interventions for CSC.

Conclusions:

• The optimal treatment strategy for Central serous chorioretinopathy (CSC) requires further investigation.
• Photodynamic therapy (PDT) and micropulse laser treatment warrant consideration for managing CSC.
• Understanding CSC's etiology and pathogenesis is crucial for developing targeted therapies.